Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
ClinicalTrials.gov study NCT05146219. IPD Sharing: NO. Countries: 1. Publications: 0.
PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06590194. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response
ClinicalTrials.gov study NCT01167244. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Symptoms Improvement in NSCLC Patients With First-Line Therapy of EGFR Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT01947868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03054038. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03396185. IPD Sharing: YES. Countries: 1. Publications: 0.
EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide
ClinicalTrials.gov study NCT03341494. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
ClinicalTrials.gov study NCT05704985. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients
ClinicalTrials.gov study NCT00551850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC
ClinicalTrials.gov study NCT05394831. IPD Sharing: NO. Countries: 3. Publications: 0.
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04762199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations
ClinicalTrials.gov study NCT06080776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
ClinicalTrials.gov study NCT01646450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03349203. IPD Sharing: YES. Countries: 1. Publications: 0.
Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
ClinicalTrials.gov study NCT04034173. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
ClinicalTrials.gov study NCT05528458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
ClinicalTrials.gov study NCT02375022. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
ClinicalTrials.gov study NCT01106781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC
ClinicalTrials.gov study NCT06585644. IPD Sharing: NO. Countries: 1. Publications: 0.
First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI
ClinicalTrials.gov study NCT05920135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.